Business News Agency May 31st According to the latest data on the competitive landscape of clinical medicines of Chinese patent medicines collected and collected by the SFDA's Southern Medicine Economic Research Institute's “Chinese Traditional Patent Medicine Hospital Monitoring Systemâ€, in Beijing, Guangzhou, Nanjing, Chongqing, Chengdu, Xi’an, Harbin, and Shenyang In sample hospitals such as Zhengzhou and Zhengzhou, the sales of proprietary Chinese medicines in 2010 increased by 22% year-on-year, and the growth rate in both of the last three years exceeded 20%. The growth rate was relatively stable.
In the major market share of Chinese patent medicines for clinical use in 2010, cardiovascular and cerebrovascular diseases, drugs for oncology, and drugs for respiratory diseases still accounted for the top 3 market share, with market shares of 37.71%, 15.94%, and 10.97%, respectively. The total accounted for nearly 65% ​​of the market share. Compared with 2009, the market share of drugs for cardiovascular and cerebrovascular diseases and drugs for oncological diseases did not change significantly, while the market share of drugs for respiratory diseases declined slightly. The market share of other drug categories did not change much from the same period last year.
Figure 2010 sales of traditional Chinese medicine in major categories
In the major market share of Chinese patent medicines for clinical use in 2010, cardiovascular and cerebrovascular diseases, drugs for oncology, and drugs for respiratory diseases still accounted for the top 3 market share, with market shares of 37.71%, 15.94%, and 10.97%, respectively. The total accounted for nearly 65% ​​of the market share. Compared with 2009, the market share of drugs for cardiovascular and cerebrovascular diseases and drugs for oncological diseases did not change significantly, while the market share of drugs for respiratory diseases declined slightly. The market share of other drug categories did not change much from the same period last year.
Figure 2010 sales of traditional Chinese medicine in major categories
A : Medications for digestive diseases (6.18% )
B : qi and blood supplements (1.31% )
C : medication for cardiovascular and cerebrovascular diseases (37.71% )
D : dermatology medication (1.91% )
E : Pediatric Use (0.94% )
F : gynecological medication (5.29% )
G : Urinary system disease medication (4.41% )
H : Medications (2.25% )
I : Oncology Medication (15.94% )
J : musculoskeletal system disease medication (8.28% )
K : Drugs for nervous system diseases (3.48% )
L : Respiratory disease medication (10.97% )
M : Other medications (1.06% )
Organic Adzuki Beans,Adzuki Beans,Red Adzuki Beans,Dried Adzuki Beans
Lixian Spring Pharmaceutical Co., Ltd. , https://www.lxctyy.com